HomeProductCardiovascular & hematopoietic systemCardiovascular & hematopoietic system

APROVEL

APROVEL

Code : APR01

Price: Contact

Manufacturer                          

  •       SANDOZ

Present/Packing          Aprovel film-coated tablet

                                         Aprovel 150 mg x 28's

                                         Aprovel 300 mg x 28's

Price                    


Features   


Delivery



Share this product to others

Shopping
guide
Add to cart

APROVEL

Manufacturer:

          Sanofi-Aventis

Contents:

          Irbesartan

Indications:

          Essential HTN. Treatment of renal disease in patients w/ HTN & type 2 DM as part of an antihypertensive drug regimen.

Contraindications:

          Pregnancy & lactation.

Special Precautions:

         Increased risk of severe hypotension in patients w/ renal artery stenosis. Periodic monitoring of K & serum creatinine in patients w/ renal impairment. Monitoring of serum K in patients, suffering from heart failure. Patients w/ recent kidney transplantation, primary aldosteronism, aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy, ischaemic cardiopathy or ischaemic CV disease.

Dosage:

          Initial & maintenance dose: 150 mg once daily. May be increased to 300 mg or other antihypertensive agents can be added. In vol-depleted patients, correct prior to administration. Elderly >75 yr & haemodialysis patients Consider initiating w/ 75 mg. Hypertensive type 2 diabetic patients Initially 150 mg once daily. Maintenance: 300 mg once daily.

Class:

          Angiotensin II Antagonists

Presentation/Packing:

          Aprovel film-coated tablet

          Aprovel 150 mg x 28's
          Aprovel 300 mg x 28's
Details:

          MyPhuocPharmacy – (08) 62581003

Irbesartan
Initial & maintenance dose: 150 mg once daily. May be increased to 300 mg or other antihypertensive agents can be added. In vol-depleted patients, correct prior to administration. Elderly >75 yr & haemodialysis patients Consider initiating w/ 75 mg. Hypertensive type 2 diabetic patients Initially 150 mg once daily. Maintenance: 300 mg once daily.
Updating
Increased risk of severe hypotension in patients w/ renal artery stenosis. Periodic monitoring of K & serum creatinine in patients w/ renal impairment. Monitoring of serum K in patients, suffering from heart failure. Patients w/ recent kidney transplantation, primary aldosteronism, aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy, ischaemic cardiopathy or ischaemic CV disease.

Rating

(based on 0 rating)

We want to know your comment!


Write a review


     
  Rating
  Email *
  Fullname *
  Title *
  Content *
  Confirm code *